We also demonstrate that MMR-associated somatic CpG hypermutation is compatible with an acceleration of the ubiquitous clock-like mutational process SBS1 and that CpG-hypermutant tumours converged on TP53-deficiency. The gene discussed is TP53; the disease is neoplasm.